Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Matsumotokiyoshi Holdings Co ( (JP:3088) ).
MatsukiyoCocokara & Co. reported a positive financial performance for the three months ending June 30, 2025, with significant year-on-year growth in net sales, EBITDA, and profits. The company saw a 5.3% increase in net sales and a 10.8% rise in profit attributable to owners of the parent, indicating strong operational efficiency and market demand. The financial outlook for the fiscal year ending March 31, 2026, remains optimistic, with projected growth in sales and profits, reflecting the company’s robust market positioning and strategic initiatives.
The most recent analyst rating on (JP:3088) stock is a Buy with a Yen3500.00 price target. To see the full list of analyst forecasts on Matsumotokiyoshi Holdings Co stock, see the JP:3088 Stock Forecast page.
More about Matsumotokiyoshi Holdings Co
MatsukiyoCocokara & Co. operates in the retail industry, primarily focusing on pharmaceuticals, cosmetics, and daily necessities. The company is listed on the Tokyo Stock Exchange and is known for its extensive network of drugstores across Japan.
Average Trading Volume: 1,352,858
Current Market Cap: Yen1357.2B
Learn more about 3088 stock on TipRanks’ Stock Analysis page.